Description
4-Fluoro-3-(trifluoromethyl)phenolMarket Outlook, 2026-2035 forecast; 2036-2047 scenarios
4-Fluoro-3-(trifluoromethyl)phenol (CAS 61721-07-1) market 2025: beflubutamid herbicide demand, suppliers, diazotisation route, regulation and outlook.
Market overview
4-F-3-CF3-phenol is a fluorinated phenol carrying both a ring fluorine and a trifluoromethyl group. Its main commercial outlet is the phenoxy half of the cereal herbicide beflubutamid, and it is also a research building block for medicinal chemistry. Supply comes from diazotisation-hydrolysis of 4-fluoro-3-trifluoromethylaniline, a step few producers run at scale.
The question this report answers
How large is demand for 4-F-3-CF3-phenol, how tied is it to beflubutamid, and who can supply it at commercial scale?
1. Demand: who uses 4-F-3-CF3-phenol and where it is growing
Beflubutamid herbicide synthesis is the largest use, with end demand in European cereals and synthesis in Europe, India and China.
Demand by application (share of 2025 consumption, Market Krystal analysis)
– Herbicide intermediates (beflubutamid): 75%
– Pharmaceutical and discovery chemistry: 18%
– Other specialty uses: 7%
No published split exists, so Market Krystal set shares from the single commercial active ingredient (beflubutamid), where it is used, and catalogue research demand.
Demand by region (share of 2025 consumption, Market Krystal analysis)
– Europe: 55%
– China: 20%
– India: 12%
– Japan: 7%
– North America: 6%
Where demand grows fastest to 2035
– Beflubutamid herbicide: Approved cereal products such as BEFLEX (500 g/L beflubutamid) keep demand steady, with growth tied to resistance management in winter cereals (ANSES)
– Discovery chemistry: Research use grows with fluorinated building-block demand but stays small in tonnage (Market Krystal estimate)
2. Supply: who makes 4-F-3-CF3-phenol and how much
Bulk supply sits with a few custom fluorochemical makers using the Ube diazotisation-hydrolysis process; TCI, Thermo Fisher and ChemShuttle supply research grades. Commercial output is indicative at 100-250 t a year from a few custom manufacturers; the industrial route was patented by Ube Industries with 85-96% yields (Ube Industries).
Main producers and capacity
– Ube Industries (UBE Corp) (Japan): Patented diazotisation-hydrolysis process; beflubutamid originator chemistry (Ube Industries / USPTO)
– TCI (Tokyo Chemical Industry) (Japan): Catalogue supply, 5-25 g, min. 98% GC (TCI / Fisher Scientific)
– Thermo Fisher Scientific (USA): Catalogue supply, 1-25 g, 97% (currently unavailable)
– ChemShuttle (USA): Catalogue research supply, 95%
Production by region (share of 2025 output, Market Krystal analysis)
– China: 55%
– India: 25%
– Japan and Europe: 20%
Trade and supply-demand balance
Asian custom manufacturers export to European beflubutamid formulators; Europe is a net importer (Market Krystal estimate).
3. Value chain: from feedstock to end market
4-Fluoro-3-trifluoromethylaniline + Sodium nitrite and sulfuric acid + Copper sulfate → 4-F-3-CF3-phenol → Herbicide intermediates (beflubutamid), Pharmaceutical and discovery chemistry
Raw materials
– 4-Fluoro-3-trifluoromethylaniline: Direct precursor; largest cost item (Ube Industries / USPTO)
– Sodium nitrite and sulfuric acid: Diazotisation reagents; acid strength controls by-products (Ube Industries / USPTO)
– Copper sulfate: Hydrolysis medium for the diazonium salt (Ube Industries / USPTO)
Production route
4-Fluoro-3-trifluoromethylaniline is converted to its sulfate, diazotised with sodium nitrite at 0-10 C and hydrolysed in aqueous copper sulfate, with steam distillation giving 85-96% yields (Ube Industries).
Downstream
The phenol is alkylated with a 2-halobutanoate and amidated with benzylamine to make beflubutamid, which is formulated into cereal herbicides such as BEFLEX.
Price, cost and margin
Cost follows 4-fluoro-3-trifluoromethylaniline and diazotisation yield; margin is high per kilogram but volumes are small. Bulk material is indicative at USD 40-60/kg, while research packs sell near GBP 23/g (Thermo Fisher Scientific). Margin sits with the producer that controls aniline supply and diazotisation yield.
Where the chain is tightest
Diazonium stability is the constraint: low acid strength or long holds drop yields to 15-76% (Ube Industries).
Who sits where in the chain
– Process technology: Ube Industries (UBE Corp)
– Active formulation: Cheminova (FMC)
– Distribution: TCI, Thermo Fisher Scientific, ChemShuttle
4. Market size: what demand, supply and price add up to
Market Krystal preliminary estimate (2025)
No research publisher sizes 4-F-3-CF3-phenol. The market is a niche agrochemical and research intermediate. Market Krystal sizes demand at roughly 80-200 t a year, driven by beflubutamid production for European cereals plus research use, valued at an indicative USD 40-60/kg for bulk material. Catalogue prices of about GBP 23 per gram (Thermo Fisher Scientific) reflect research packs, not bulk. On this basis we use USD 3-12 mn. Confidence grade C: no published estimate; built bottom-up from capacity, trade and price data.
How published estimates compare
No publisher sizes this molecule. Market Krystal builds the range from beflubutamid demand and research use valued at indicative bulk prices.
Key figures at a glance (third-party, cited)
– Ube process yields 85-90%, and up to 96% with steam distillation, versus 15-76% in comparative runs (Ube Industries)
– BEFLEX contains 500 g/L beflubutamid and was authorised in France in Jun 2017 (ANSES)
– EU approval period for beflubutamid extended by Implementing Regulation (EU) 2020/869 (European Commission / EFTA)
– Research grade sells at about GBP 23.27 per gram (Thermo Fisher Scientific)
5. Outlook to 2035 and scenarios to 2047
Regulation and substitution
Demand depends on EU approval of beflubutamid, extended by Implementing Regulation (EU) 2020/869; loss of approval would remove most volume.
Recent developments among key stakeholders
– Jun 2020: Commission Implementing Regulation (EU) 2020/869 extended the EU approval period of beflubutamid (European Commission / EFTA)
– Jun 2017: ANSES authorised Cheminova's BEFLEX (500 g/L beflubutamid) for winter wheat, barley, rye and triticale (ANSES)
– Apr 2011: Ube's US process patent for the phenol lapsed, opening the route to other producers (USPTO)
What this means for the market
Beflubutamid formulators depend on a very small supplier pool, so a single plant outage can stop supply. With the Ube process patent lapsed, Indian and Chinese custom manufacturers can enter. Any change to the EU status of beflubutamid would move most of the market.
Strategic scenarios to 2047
– Base: Volume grows 2-4% a year to 2035 with beflubutamid use in European cereals, then flat to 2047.
– Constrained supply: Loss of one custom manufacturer halts beflubutamid production for a season and doubles spot prices.
– Technology transition: Direct fluorination or flow diazotisation lowers cost and opens pharma uses.
The swing factor for 4-F-3-CF3-phenol is EU renewal of beflubutamid. Signposts: EU renewal decisions on beflubutamid, new national product authorisations, Indian custom-synthesis contracts, aniline precursor prices.
What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: Herbicide intermediates, Pharmaceutical and discovery chemistry, Other specialty uses; end use: Beflubutamid, Cereal herbicide formulations, Research building blocks; region: Europe, China, India, Japan, North America. Each segment is backed by a producer capacity map, trade data and the Market Krystal estimate log, with scenarios to 2047 and strategic recommendations.
Table of contents
- Executive summary: key findings, figures and Market Krystal view
- Chemical identity, grades, specifications and CAS scope
- Demand by application and end market
- Regional demand and fastest-growing uses
- Supply: global producers, plant sites and capacity
- Trade flows and regional supply-demand balance
- Value chain: feedstocks, production routes and cost structure
- Pricing history 2020-2025, margins and procurement benchmarks
- Competitive landscape and company profiles
- Regulation, EHS and substitution risk
- Beflubutamid: registrations, crops and demand model
- Diazotisation-hydrolysis process economics and the Ube patent
- Custom manufacturing of fluorinated phenols in India and China
- Market Krystal estimate, evidence log and reconciliation with published estimates
- Forecast 2026-2035: volume and value by segment and region
- Scenarios to 2047: base, constrained supply and technology transition
- Strategic recommendations and commercial opportunities
- Methodology, sources and assumptions
Companies covered
| Company | Role in the value chain | Stage |
|---|---|---|
| Ube Industries (UBE Corp) | Process patent holder and beflubutamid chemistry originator | Process technology |
| Cheminova (FMC) | Registrant of BEFLEX beflubutamid herbicide in France | Active formulation |
| TCI | Catalogue supplier of research grades | Distribution |
| Thermo Fisher Scientific | Catalogue supplier of research grades | Distribution |
| ChemShuttle | Building-block supplier for discovery chemistry | Distribution |
Company profiles, plant details and capacity estimates are in the full report.
Recent developments
- 1 Nov 1996 · Ube IndustriesUS5892126A: Process for preparing 4-fluoro-3-trifluoromethylphenol ↗
- 1 Jun 2020 · European Commission (via EFTA)Implementing Regulation (EU) 2020/869 ↗
- 29 Oct 2026 · TCI4-Fluoro-3-(trifluoromethyl)phenol 98.0+% ↗
- 29 Oct 2026 · Thermo Fisher Scientific4-Fluoro-3-(trifluoromethyl)phenol, 97% ↗
Applications and use cases
The phenol forms the 4-fluoro-3-trifluoromethylphenoxy unit of beflubutamid, a pre- and early post-emergence cereal herbicide.
End users: Agrochemical manufacturers and formulatorsIt serves as a fluorinated phenol building block for aryl ether drug candidates.
End users: Pharma discovery groups and CROsIt is used to make phenoxy-amide analogues in herbicide discovery.
End users: Crop-protection R&D teamsStrategy and recommendations
Offer the phenol plus downstream beflubutamid steps as a custom-synthesis package.
The process patent has lapsed and formulators want fewer supply hand-offs.Qualify a second source and hold six months of stock.
The supplier pool is very small and outages are hard to cover.Treat the phenol as part of a broader fluorinated aniline and phenol platform.
Stand-alone volume is too small to justify dedicated capacity.Full strategy, scenarios and company-level recommendations are in the report.
How the research is built
Company releases, filings, regulatory material, customs and trade information, patents and documented market signals support the analysis. Disclosed facts are separated from Market Krystal estimates and scenario assumptions.
The delivery can be customized around a region, supplier set, application, customer universe or sourcing decision.
What this research is designed to answer
- How many tonnes of 4-F-3-CF3-phenol does beflubutamid production consume each year?
- Who can supply the phenol at commercial scale after the Ube patent lapse?
- What does the EU regulatory path for beflubutamid mean for demand to 2035?
- How sensitive is cost to aniline precursor price and diazotisation yield?
- Is there pharma demand that could diversify the market?
BUILT AROUND YOUR DECISION
Need a specific company, region or customer question answered?
Request the sample and tell us the commercial decision behind your research. We will confirm the relevant scope before delivery.
REQUEST REPORT SAMPLE
Reviews
There are no reviews yet.